BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MedNet - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mednetus.net
X-WR-CALDESC:Events for MedNet
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250312T080000
DTEND;TZID=America/New_York:20260312T170000
DTSTAMP:20260422T184648
CREATED:20250620T061332Z
LAST-MODIFIED:20250620T062541Z
UID:10000002-1741766400-1773334800@mednetus.net
SUMMARY:Ocular Surface Disease: Pathophysiology\, Evaluation\, Management with Topical Agents\, and Neuromodulation
DESCRIPTION:CME | 1.25 Credits \n\n\n\n\n\n\nWebcast \nTime to Complete: 75 minutes \nReleased: March 12\, 2025 \nExpires: March 12\, 2026 \nMaximum Credits:\n1.25 / AMA PRA Category 1 CreditsTM \n\n\n\n\n\n\n\n\n\nStart Activity\n\n\n\nProgram Description \nThis webcast provides an update on the ocular surface diseases. Cornea and conjunctiva\, lids\, exocrine glands and their innervation form an integrated entity\, which regulates the production of tear fluid.1 Stable tear fluid is essential in nourishing and protecting the ocular surface from external threats\, such as pollution\, desiccation\, injuries\, allergens and pathogens. Maintaining and protecting the transparent\, avascular cornea is particularly important for good visual acuity. Thus\, an integral part of the functioning of the ocular surface relies on the tear fluid. \nIntended Audience \nOphthalmologists\, optometrists\, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with ocular surfaces diseases. \nCommercial Supporter \nThis activity is supported by an educational grant from Dompé US Inc. \n\n\n\n\n\n\n\n\nLearning Objectives \nUpon completion of the educational activity\, participants should be able to: \n\nSummarize the pathophysiology\, risk factor\, and evaluation of ocular surface disease\nInterpret data on artificial tear formulations and neuromodulation in managing ocular surface disease\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAccredited Providers \nThis activity is provided by Amedco and MedNet. \n       \nJoint Accreditation Statement \nIn support of improving patient care\, Amedco and MedNet have planned and implemented this activity. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. MedNet serves as the content and logistic provider for this activity. Amedco designates this activity for 1.25 AMA PRA Category 1 CreditsTM \nPhysicians Credit Designation \nAmedco designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAdditional Credit Information \nPhysician Assistants\nAAPA accepts AMA PRA Category 1 CreditTM for the PRA from organizations accredited by ACCME. Maximum of 1.25 hours. \nNurse Practitioners\nThe American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors\, and allows reciprocity for AANPCP continuing education credit. Maximum of 1.25 hours. \nThrough an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists\, physicians and healthcare providers may convert CME/CE PRA Category 1 CreditsTM to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has recognition agreements with the AMA for live events and e-learning materials. \nFaculty \n \nSarah B. Sunshine\, MD\nAssistant Professor\, Ophthalmology\nUniversity of Maryland and Greenebaum Comprehensive Cancer\nBaltimore\, MD \nDr. Sunshine discloses the following:\nConsultant: Astra Zeneca\, GSK\nResearch Support: Incyte (IIT)\, Eversight\, NIH \n\nInstructions \nIn order to receive CME/CE credits\, participants must complete the pre-assessment questions\, post-assessment\, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript\, which you can access at any time. \nACCME – Amedco\nPhone Number: 651-789-3730\nE-Mail: Sheryl@amedcoemail.com \nPrivacy Policy \nmyCME privacy policy
URL:https://mednetus.net/event/ocular-surface-disease-pathophysiology-evaluation-management-with-topical-agents-and-neuromodulation/
CATEGORIES:Webcast
ATTACH;FMTTYPE=image/jpeg:https://mednetus.net/wp-content/uploads/2025/06/032rt0jpt6u4-OSD800x450.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250416T080000
DTEND;TZID=America/New_York:20260416T170000
DTSTAMP:20260422T184648
CREATED:20250620T070737Z
LAST-MODIFIED:20250620T070737Z
UID:10000012-1744790400-1776358800@mednetus.net
SUMMARY:Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
DESCRIPTION:CME | 1.25 Credits \n\n\n\nWebcast \nTime to Complete: 75 minutes \nReleased: April 16\, 2025 \nExpires: April 16\, 2026 \nMaximum Credits:\n1.25 / AMA PRA Category 1 CreditsTM \nResume Activity \nProgram Description \nThis enduring webcast program explores the latest advancements in tear-stimulating therapies. Dive into current treatments and discover novel approaches poised to revolutionize patient outcomes. This activity promises to provide invaluable insights and practical strategies for healthcare professionals dedicated to improving eye health. \nIntended Audience \nOphthalmologists\, optometrists\, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with dry eye disease \nCommercial Supporter \nSupported by an unrestricted educational grant from Oyster Point. \n\nLearning Objectives \nUpon completion of the educational activity\, participants should be able to: \n\nSummarize the pathophysiology and factors contributing to DED\, such as preservatives in topicals\, refractive or cataract surgery\, menopause\, and autoimmune diseases\nAssess real-world evidence surrounding available and new tear-stimulating therapies to improve patient outcomes of individuals with DED\n\nAccredited Providers \nThis activity is provided by Amedco and MedNet. \n   \nJoint Accreditation Statement \nIn support of improving patient care\, Amedco and MedNet have planned and implemented this activity. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. MedNet serves as the content and logistic provider for this activity. Amedco designates this activity for 1.25 AMA PRA Category 1 CreditsTM \nPhysicians Credit Designation \nAmedco designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAdditional Credit Information \nNote to Physician Assistants\nAAPA accepts AMA PRA Category 1 CreditTM for the PRA from organizations accredited by ACCME. Maximum of 1.25 hours. \nNote to Nurse Practitioners\nThe American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors\, and allows reciprocity for AANPCP continuing education credit. Maximum of 1.25 hours. \nThrough an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists\, physicians and healthcare providers may convert CME/CE PRA Category 1 CreditsTM to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has recognition agreements with the AMA for live events and e-learning materials. \nFaculty \n> \nNeal Guymon\, OD\nOptometrist\nSummit EyeCare\nIdaho Falls\, ID \nDr. Guymon discloses the following:\nContent Creator: TearRestore Inc. and Danelli Ocular Creations; Affiliate for Danelli Ocular Creations \n \nEric D. Donnefeld\, MD\nClinical Professor of Ophthalmology\nNew York University Langone Medical Center\nOphthalmic Consultants of Long Island\nNew York\, NY \nDr. Donnefeld discloses the following:\nSpeaker: Allegro\, Abbvie\, Alcon\, AVTRMed\, Aurion\, Bausch & Lomb\, CorneaGen\, Covalent\, CRST\, Crystilex\, BVI\, Blephex\, ELT Sight\, EyePoint Pharma\, Foresight\, Glaukos\, Horizon Surgical Systems\, Inversa\, Johnson & Johnson\, Kala\, Katena\, Lacripen\, LayerBio\, LensGen\, Mati Pharmaceuticals\, Melt Pharmaceuticals\, MDBackline\, MOA\, Nordic Pharma\, Novabay\, Ocular Innovations\, Oculis\, Omega Ophthalmics\, Ocuhub\, PRN\, Rayner\, ReTear\, Singular\, Strathspey Crown\, Surface\, Tarsus\, Tearscience\, Tenpoint Pharma\, Versant Ventures\, Visionary Venture\, and Zeiss \nInstructions \nIn order to receive CME/CE credits\, participants must complete the pre-assessment questions\, post-assessment\, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript\, which you can access at any time. \nACCME – Amedco\nPhone Number: 651-789-3730\nE-Mail: justin@amedcoemail.com \nPrivacy Policy \nmyCME privacy policy
URL:https://mednetus.net/event/dry-eye-disease-current-and-emerging-novel-tear-stimulating-therapies-for-improved-outcomes-2/
CATEGORIES:Live Program
ATTACH;FMTTYPE=image/jpeg:https://mednetus.net/wp-content/uploads/2025/06/wsi48i3zt0wr-Enduring800x450.jpg
END:VEVENT
END:VCALENDAR